Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Differential Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Treatment Type (Chest Pain, Headache, Fever, Pneumonia, Hypertension, Fatigue, Sleep Problems), By Usability, By End Use, By Region and Competition" report has been added to ResearchAndMarkets.com's offering.
Global Differential Diagnostics Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028.
This can be ascribed to the increasing prevalence of various types of diseases such as influenza, COVID diseases, cardiac diseases, and infectious diseases across the globe. Also, the growing accessibility of point-of-care testing products through online platforms will drive the growth of the market in the forecast period.
Similarly, growing healthcare decentralization and high investments and funding for project development are expected to enhance the growth of the differential diagnostic market in the coming years. The availability of affordable diagnostic tests for chronic illness in the developing region is anticipated to propel the growth of the market. In January 2022, the Therapeutic Goods Administration (TGA) granted provisional approval for Novavax's COVID-19 vaccine branded as Nuvaxovid for use in Australia.
Rising Diagnostic Tests
Due to the growing number of diagnostic tests, people are demanding the best diagnostic test which will easily detect diseases and is anticipated to boost the growth of the market during the forecasted period. Diagnostic tests are performed in a private or public laboratory with appropriate equipment and sometimes expensive instrumentation and staffed with trained and qualified personnel.
Growing demand for point-of-care testing which occurs at the nearest site of patient care is sought in the field of infectious bacterial diagnostics to allow the care team to receive more results quickly and make immediate and informed management decisions. For molecular diagnosis, different types of diseases can be detected by using challenging differential diagnosis.
Governments and different organizations are investing for research and development purposes in the healthcare sector which is a major factor in driving the growth of the differential diagnostics market during the forecasted period. In 2021, according to the National Aids Control Organization (NACO), approximately 2.40 million people in India were infected with HIV.
Of the total HIV-infected population 45% were women and 2% were below 12. Also, a growing number of clinics will enhance the demand for differential diagnostic tests market over the years. According to the Non-communicable Diseases Key Facts published by the World Health Organization (WHO) in April 2021, chronic diseases kill around 41 million people each year, which is equivalent to 71% of all deaths worldwide.
Growing Technological Advancements
Growing advancements in diagnostic technology helped physicians to evaluate processes and events in real time. The clinical application of advances in physics and mathematics resulted in the development of diagnostic tools. These developments help physicians to get more accurate, less invasive, and less expensive which will boost the market growth during the forecasted years.
Also, the growing demand for diagnostic kits for at-home usage has resulted in technical developments which are expected to create significant growth in the forecast period. Leica Microsystems, a Danaher subsidiary, declared the debut of STELLARIS, the company's flagship platform for its revolutionary confocal microscope, in April 2020. This platform allows the viewing of live tissues and cells in three dimensions.
Report Scope:
In this report, Global Differential Diagnostics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Differential Diagnostics Market, By Treatment Type:
- Chest Pain
- Headache
- Fever
- Pneumonia
- Hypertension
- Fatigue
- Sleep Problems
Differential Diagnostics Market, By Usability:
- Physical Health Disorders
- Mental Health Disorders
Differential Diagnostics Market, By End Use:
- Hospitals
- Diagnostic Centers
- Others
Differential Diagnostics Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Turkey
Key Topics Covered:
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Differential Diagnostics Market Outlook
6. North America Differential Diagnostics Market Outlook
7. Europe Differential Diagnostics Market Outlook
8. Asia-Pacific Differential Diagnostics Market Outlook
9. South America Differential Diagnostics Market Outlook
10. Middle East and Africa Differential Diagnostics Market Outlook
11. Market Dynamics
12. Market Trends & Developments
13. Global Differential Diagnostics Market: SWOT Analysis
14. Porter's Five Forces Analysis
15. Competitive Landscape
16. Strategic Recommendations
A selection of companies mentioned in this report includes
- Thermo Fisher Scientific Inc.
- Hologic, Inc.
- Quidel Corporation.
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories, Inc.
- Danaher Corporation
- Meridian Bioscience Inc.
- GenMark Diagnostics, Inc.
- Sekisui Diagnostics Co., Ltd.
- Luminex Corporation.
For more information about this report visit https://www.researchandmarkets.com/r/kwe56k
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
